Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study
Frontiers in Public Health · 17.03.2026 · 14
DOI: 10.3389/fpubh.2026.1779404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 17.03.2026. Verfasst von Andre A N Bovell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: Breast Neoplasms, Health Care Costs, Cost of Illness. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of KwaZulu-Natal.
Abstract (Originalsprache)
Background
Female breast cancer still represents a substantial public health obstacle in many countries. The condition remains costly for healthcare providers and imposes heavy burdens on healthcare systems in countries globally. There is a significant gap in information regarding the economic burden of carcinoma of the breast affecting the women of Antigua and Barbuda. Consequently, this research aims to quantify the costs related to female breast carcinoma from the perspective of the healthcare provider in the country.
Methods
This study employed a prevalence-based cost of illness methodology. Data on female breast cancer were collected from four research sites in Antigua and Barbuda for the years 2017 to 2021 to calculate the average yearly prevalence. Both top down and bottom up costing methods were employed to compute direct medical costs, using the price levels from 2021 and converting the amounts to United States Dollars.
Results
Estimated total annual direct medical costs for female breast carcinoma was USD3.1 million. Treatment for clinical stages I to IV accounted for 78% of costs. Our leading contributors to annual direct medical costs were treatment (USD2,458,305.82), post-treatment care (USD390,474.79), and diagnosis and imaging (USD143,045.38). Overall direct medical unit costs was estimated at USD177,618.02, with lead drivers being surgery, systemic therapy, and ‘other complications of treatment’.
Conclusion
Our study presented findings regarding direct medical costs of female breast carcinoma in Antigua and Barbuda. Our cost estimates appeared considerable given the local context. These findings provided a reference for informing health policy, advising on resources allocation, and encouraging cost containment in female breast cancer management in Antigua and Barbuda.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
- Health and Social Transformation Unit, Organisation of Eastern Caribbean States, Castries, Saint Lucia.
- Cancer & Infectious Diseases Epidemiology Research Unit (CIDERU), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Förderung
- University of KwaZulu-Natal
Zitieren
APA
Bovell, A. A. N., Ngcamphalala, C., Brizan-St Martin, R., Ncayiyana, J., & Ginindza, T. G. (2026). Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1779404
Vancouver
Bovell AAN, Ngcamphalala C, Brizan-St Martin R, Ncayiyana J, Ginindza TG. Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1779404
BibTeX
@article{Bovell2026,
author = {Bovell, Andre A N and Ngcamphalala, Cebisile and Brizan-St Martin, Roxanne and Ncayiyana, Jabulani and Ginindza, Themba G},
title = {Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1779404}
}
EUVIMED